# Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome

> **NCT04615455** · PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 40 (actual)

## Conditions studied

- Keratoconjunctivitis Sicca, in Sjogren's Syndrome

## Interventions

- **DRUG:** ASCs
- **DRUG:** Cryostor CS10

## Key facts

- **NCT ID:** NCT04615455
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-03
- **Primary completion:** 2022-12-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04615455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04615455, "Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04615455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*